Skip to main content
Log in

The Value of Value of Information

Best Informing Research Design and Prioritization Using Current Methods

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Value of information (VOI) methods have been proposed as a systematic approach to inform optimal research design and prioritization. Four related questions arise that VOI methods could address. (i) Is further research for a health technology assessment (HTA) potentially worthwhile? (ii) Is the cost of a given research design less than its expected value? (iii) What is the optimal research design for an HTA? (iv) How can research funding be best prioritized across alternative HTAs?

Following Occam’s razor, we consider the usefulness of VOI methods in informing questions 1–4 relative to their simplicity of use. Expected value of perfect information (EVPI) with current information, while simple to calculate, is shown to provide neither a necessary nor a sufficient condition to address question 1, given that what EVPI needs to exceed varies with the cost of research design, which can vary from very large down to negligible. Hence, for any given HTA, EVPI does not discriminate, as it can be large and further research not worthwhile or small and further research worthwhile. In contrast, each of questions 1–4 are shown to be fully addressed (necessary and sufficient) where VOI methods are applied to maximize expected value of sample information (EVSI) minus expected costs across designs.

In comparing complexity in use of VOI methods, applying the central limit theorem (CLT) simplifies analysis to enable easy estimation of EVSI and optimal overall research design, and has been shown to outperform bootstrapping, particularly with small samples. Consequently, VOI methods applying the CLT to inform optimal overall research design satisfy Occam’s razor in both improving decision making and reducing complexity. Furthermore, they enable consideration of relevant decision contexts, including option value and opportunity cost of delay, time, imperfect implementation and optimal design across jurisdictions.

More complex VOI methods such as bootstrapping of the expected value of partial EVPI may have potential value in refining overall research design. However, Occam’s razor must be seriously considered in application of these VOI methods, given their increased complexity and current limitations in informing decision making, with restriction to EVPI rather than EVSI and not allowing for important decision-making contexts. Initial use of CLT methods to focus these more complex partial VOI methods towards where they may be useful in refining optimal overall trial design is suggested. Integrating CLT methods with such partial VOI methods to allow estimation of partial EVSI is suggested in future research to add value to the current VOI toolkit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Table I

Similar content being viewed by others

Notes

  1. EVPI is the expected value of losses avoided with perfect information, which reflects integration of the probability and associated losses where INB is less than 0.

  2. EVSI of any given research design represents the expected value of that research in reducing losses associated with the probability of INB being less than 0. This is calculated as EVPI with current information less the expectation of EVPI when information is updated from that design.

  3. Adopt and trial may be feasible and ethical for rare cases in which positive while uncertain INB is driven by lower cost rather than expected net clinical benefit, or where there is no access to healthcare outside a trial setting (e.g. uninsured populations in the US).

References

  1. Eckermann S, Willan AR. Expected value of information and decision making in HTA. Health Econ 2007 Feb; 16 (2): 195–209

    Article  PubMed  Google Scholar 

  2. Eckermann S, Briggs A, Willan AR. Health technology assessment in the cost-disutility plane. Med Decis Making 2008 Apr 1; 28 (2): 172–81

    Article  PubMed  Google Scholar 

  3. Sculpher M, Claxton K. Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty: when is there sufficient evidence? Value Health 2005; 8 (4): 433–46

    Article  PubMed  Google Scholar 

  4. Claxton K, Sculpher M. Using value of information analysis to prioritise health research: some lessons from recent UK experience.Pharmacoeconomic 2006; 24 (11): 1055–68

    Article  Google Scholar 

  5. Eckermann S, Willan AR. Globally optimal trial design for local decision making. Health Econ 2009; 18 (2): 203–16

    Article  PubMed  Google Scholar 

  6. Willan AR, Eckermann S. Optimal clinical trial design using value of information methods with imperfect implementation. Health Econ 2010; 19 (5): 549–61

    PubMed  Google Scholar 

  7. Eckermann S, Willan AR. Time and expected value of sample information wait for no patient. Value Health 2008; 11 (3): 522–6

    Article  PubMed  Google Scholar 

  8. Eckermann S, Willan AR. The option value of delay in health technology assessment. Med Decis Making 2008 Jun 1; 28 (3): 300–5

    Article  PubMed  Google Scholar 

  9. Willan AR, Pinto EM. The expected value of information and optimal clinical trial design [published erratum appears in Stat Med 2006]; 25: 720]. Stat Med 2005; 24: 1791–806

    Article  PubMed  Google Scholar 

  10. Willan AR. Clinical decision making and the expected value of information. Clin Trials 2007 Jun 1; 4 (3): 279–85

    Article  PubMed  Google Scholar 

  11. Willan A, Kowgier M. Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods. Clin Trials 2008 Aug 1; 5 (4): 289–300

    Article  PubMed  Google Scholar 

  12. Nixon RM, Wonderling D, Grieve RD. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared. Health Econ 2010; 19 (3): 316–33

    Article  PubMed  Google Scholar 

  13. Briggs AH, Mooney CZ, Wonderling DE. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Stat Med 1999; 18 (23): 3245–62

    Article  PubMed  CAS  Google Scholar 

  14. Spiegelhalter DJ. Incorporating bayesian ideas into healthcare evaluation. Stat Sci 2004; 19 (1): 156–74

    Article  Google Scholar 

  15. Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Making 2004 Mar 1; 24 (2): 207–27

    Article  PubMed  CAS  Google Scholar 

  16. Australian National Health and Medical Research Council. Strategic plan. Sydney (NSW): Australian Government, 2007–9 [online]. Available from URL: http://www.nhmrc.gov.au/publications/synopses/nh80syn.htm [Accessed 2010 May 17]

    Google Scholar 

  17. UK Medical Research Council. Mission statement. London: UK Medical Research Council, 2009 [online]. Available from URL: http://www.mrc.ac.uk/About/Missionstatement/index.htm [Accessed 2010 May 17]

    Google Scholar 

Download references

Acknowledgements

The data models and methodology used in the research are not subject to any proprietary interests. Professor Willan is funded through the Discovery Grant Program of the Natural Sciences and Engineering Research Council of Canada (grant number 44868–03).

No sources of funding were used to assist in the preparation of this article. The authors have no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simon Eckermann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eckermann, S., Karnon, J. & Willan, A.R. The Value of Value of Information. Pharmacoeconomics 28, 699–709 (2010). https://doi.org/10.2165/11537370-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11537370-000000000-00000

Keywords

Navigation